Insmed has opened a new research center in Cambridge, UK, where its researchers are looking to generate a new class of drugs to treat genetic diseases based on ‘synthetic rescue.’
The opening of the state-of-the art 17,000 square foot facility is part of a major expansion of US-headquartered Insmed’s commercial...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?